comparemela.com

Latest Breaking News On - Singapore health sciences authority - Page 18 : comparemela.com

CorDx COVID-19 Antigen Test Receives Approval for Use in Singapore

/PRNewswire/ CorDx, a global leader in the development, manufacturing, and distribution of diagnostics and other medical devices, recently received.

United statesJeff yufeng liPrnewswire cordxSingapore health sciences authorityCordx unionHealth sciences authority

Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results

Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesLorna williamsCue health incCue health nasdaqSingapore health sciences authorityEuropean unionCue healthIndia central drugs standard control organizationHealth canadaInterim orderCentral drugs standard control organizationHealth sciences

Remidio Innovative Solutions: Remidio s Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval

World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ Remidio

United kingdomCity ofDivya raoDennis riedlShivanthika muruganSobha sivaprasadPrnewswire remidioSingapore health sciences authorityHealth sciences authorityMedical directorConsultant ophthalmologistMoorfields eye hospital

Remidio s Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) receives EU MDR Class II Regulatory Approval

Bangalore (Karnataka) [India], February 23 (ANI/PRNewswire): Remidio has received CE mark approval for its Medios AI, to detect Referable DR

United kingdomCity ofDivya raoSobha sivaprasadSingapore health sciences authorityHealth sciences authorityMedical directorConsultant ophthalmologistMoorfields eye hospitalRemidio sEws india

Remidio s Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval

/PRNewswire/ Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from.

United kingdomCity ofDivya raoShivanthika muruganSobha sivaprasadSingapore health sciences authorityRemidio innovative solutionsHealth sciences authorityMedical directorConsultant ophthalmologistMoorfields eye hospital

vimarsana © 2020. All Rights Reserved.